Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants
Addison K. May
, Robert G. Sawyer
, Thomas Gleason
, Anne Whitworth
,
Timothy L. Pruett
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Escherichia Coli
100%
Genetic Engineering
100%
Cytokine Response
100%
Hemolysin
100%
Tumor Necrosis Factor-α
100%
Non-haemolytic
100%
Interleukin-1β
87%
Lipopolysaccharide
37%
Factor Level
25%
Serum Interleukins
25%
Leukocytes
12%
Virulence
12%
Exotoxins
12%
Bacterial Virulence
12%
Human Monocytes
12%
Inoculum
12%
Isogenic Strains
12%
Balb C Mice
12%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Cytokine Response
100%
Escherichia coli
100%
Hemolysin
100%
Interleukin 1
87%
Fibrinogen
50%
In Vitro
37%
Serotype
25%
Inoculum
12%
Leukocyte
12%
Bacterial Virulence
12%
Bagg Albino Mouse
12%
Exotoxin
12%
Veterinary Science and Veterinary Medicine
Escherichia coli
100%
Neoplasm
100%
Mouse
12%
BALB/c
12%
Leukocyte
12%